Related Experiment Videos

A virus-virus interaction circumvents the virus receptor requirement for infection by pathogenic retroviruses

David L Wensel1, Weihua Li, James M Cunningham

  • 1Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts 02115, USA.

Journal of Virology
|March 1, 2003
PubMed

Insights

Recombinant retroviruses spread by binding to receptors or activating other viruses. This dual infection mechanism accelerates leukemia development by enabling faster cell-cell fusion and spread.

Area of Science:

  • Virology
  • Molecular Biology
  • Oncology

Background:

  • C-type retrovirus infections increase leukemia risk via insertional gene activation.
  • Recombinant retroviruses, like murine mink cell focus-inducing (MCF) viruses, enhance infection through altered envelope glycoproteins and receptor binding.

Purpose of the Study:

  • To investigate the infection mechanisms of MCF viruses.
  • To elucidate the role of the Syg1 receptor and alternative pathways in MCF virus spread.
  • To understand how virus-virus interactions influence retroviral pathogenesis.

Main Methods:

  • Analysis of MCF virus infection pathways in permissive human cells.
  • Investigation of Syg1 receptor-dependent and -independent infection routes.
  • Assessment of trans activation effects on viral spread and cell-cell fusion.

Main Results:

  • MCF virus utilizes both Syg1 receptor-dependent and independent pathways for infection.
  • Trans activation, via ecotropic virus glycoprotein on cell surfaces, facilitates MCF virus fusion in trans.
  • Parallel functioning of these pathways accelerates MCF virus spread and cell-cell fusion.

Conclusions:

  • Pathogenic retroviral infection can be initiated by direct receptor binding or by interactions with other viral glycoproteins on cell surfaces.
  • Cooperative virus-virus interactions play a significant role in shaping retroviral quasispecies and disease progression.
  • Understanding these complex interactions is crucial for developing strategies against retroviral infections and associated leukemias.

Related Concept Videos